EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Efficacy and safety of immunizing cats against pox with the MVA attenuated strain of vaccinia virus



Efficacy and safety of immunizing cats against pox with the MVA attenuated strain of vaccinia virus



Untersuchungen uber die Wirksamkeit und Unschadlichkeit einer Schutzimpfung von Katzen gegen Pocken mit MVA Lebendimpfstoff: 65 pp.



About 2% of German cats possessed antibody to orthopoxvirus, and cases of cat pox were reported occasionally. Cats were successfully immunized with 107 CCID50 of "MVA" (Modified Vaccinia Ankara) vaccine.

Accession: 002367323

Download citation: RISBibTeXText



Related references

Safety and efficacy of attenuated fowl pox virus for immunizing chicks and chickens. Mh. Tierheilk. 14: 175-188, 1962

The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Canadian Journal of Comparative Medicine 44(2): 169-176, 1980

An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 230(3): 283-297, 1975

Safety and efficacy of an antirabies vaccine (vaccinia-rabies recombinant virus) given by mouth to foxes, dogs and cats. Annales de Recherches Veterinaires 20(2): 195-204, 1989

Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. Journal of Virology 74(16): 7651-7655, 2000

Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus. Developments in Biological Standardization 84: 195-200, 1995

Increased safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccinia virus vaccines. Journal of Medical Primatology 29(3-4): 277, August, 2000

Safety and efficacy of an attenuated Chinese QX-like infectious bronchitis virus strain as a candidate vaccine. Veterinary Microbiology 180(1-2): 49-58, 2016

Efficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens. Avian Pathology 40(1): 93-102, 2011

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus: Poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 19(4-5): 483-491, 15 October, 2000

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 19(4/5): 483-491, 2001

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. Clinical Infectious Diseases 42(8): 1102-1110, 2006

Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo. 3. Safety and efficacy during the first 21 months of study. Bulletin of the World Health Organization 24: 785-792, 1961

An attenuated strain of Western equine encephalitis virus as a possible live immunizing agent. Proceedings, Annual Meeting of the United States Animal Health Association 68: 24-40, 1964